Activity Dates: 04/30/2012 - 04/30/2015
This course is closed. Please look for other available products in CPNP University.
This 2-hour, 2-part interactive presentation provides an excellent opportunity to gain a comprehensive review of drug-induced movement disorders for both new practitioners and experienced clinicians alike. Utilize movement disorder rating scales to be able to recognize and evaluate the signs and symptoms of pseudoparkinsonism, akathisia, and tardive dyskinesia. Hone your clinical assessment skills with CPNP Movement Disorder DVD speakers Roger W. Sommi, Jr., and Steven C. Stoner in hour two of this session offering application of concepts via cases.
You will proceed through the following steps to satisfactorily complete this course:
This session was presented live at the 2012 CPNP Annual Meeting. A PDF file of the slides and audio of the speaker’s presentation is provided. ACPE transcripts can be retrieved by participants online at cpnp.org and the credit will be automatically submitted to your account at CPE Monitor shortly after the evaluation is completed.
CPNP has invested in supporting the most popular web browsers and leveraging software that our members use daily. Beyond PDF downloads, the rest of the system is built on HTML5, a technology that most up-to-date browsers will support. To access CPNP course materials online, you will need:
CPNP web sites no longer fully support Microsoft Internet Explorer 9 and older or Windows Vista and older. We cannot guarantee that the site will function perfectly on every device and configuration, but using the latest version of the software above will greatly improve your experience.
Roger W. Sommi, Jr., PharmD, FCCP, BCPP
Steven C. Stoner, PharmD, BCPP
ACPE Credit
The College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
CME Credit
Sponsored by the University of Arizona College of Medicine at the Arizona Health Sciences Center.
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the Joint sponsorship of The University of Arizona College of Medicine at the Arizona Health Sciences Center and the College of Psychiatric and Neurologic Pharmacists. ACCME credit is no longer available for this course.
Nursing Credit
ACPE and ACCME approved contact hours are accepted for ANCC Certification Renewal (as quoted on the ANCC website): “Other health disciplines' continuing education hours may be used if the content is applicable to your area of certification. ACPE and ACCME are specifically listed as approved credit types.
2011-2012 Continuing Medical Education Committee
University of Arizona College of Medicine at the Arizona Health Sciences Center
Disclosures of Interest
Name | Disclosures of Interest |
---|---|
Srikar Adhikari, MD, MS, RDMS | No Relevant Financial Relationships to Disclose |
Helen Amerongen, PhD | No Relevant Financial Relationships to Disclose |
Alan D. Bedrick, MD | No Relevant Financial Relationships to Disclose |
Edward D. French, PhD | No Relevant Financial Relationships to Disclose |
Lisa M. Kopp, DO | No Relevant Financial Relationships to Disclose |
Raymond B. Runyan, PhD | No Relevant Financial Relationships to Disclose |
Sammy C. Campbell, MD Medical Director, OCME Ex-Officio Member |
No Relevant Financial Relationships to Disclose |
John M. Harris Jr., MD, MBA Director, OCME Ex-Officio Member |
No Relevant Financial Relationships to Disclose |
2012 CPNP Program Committee
Disclosures of Interest
Name | Disclosure of Interest |
---|---|
Kristen Allison, PharmD, BCPS Clinical Pharmacist Southern Arizona VA HCS Tucson, AZ |
No Relevant Financial Relationships to Disclose |
Jennifer Bean, PharmD, BCPS Clinical Pharmacy Specialist VA-Tennessee Valley Healthcare System Murfreesboro, TN |
Employment: VA-Tennessee Valley Healthcare System, University of Tennessee College of Pharmacy Educational Grants, Research Grants or Contracts: American Society of Health System, Federal Grant Co-Investigator |
Jacquelyn Canning, PharmD Assistant Professor Albany College of Pharmacy and Health Sciences Albany, NY |
Employment: Albany College of Pharmacy and Health Sciences Department of Pharmacy Practice Assistant Professor |
Jamie C. Holmes, PharmD Assistant Professor of Pharmacy Practice Rosalind Franklin University of Medicine and Science North Chicago, IL |
Employment: Rosalind Franklin University of Medicine and Science, CAPT James A. Lovell Federal Health Care Center |
Rania Kattura, PharmD, MS, BCPP Clinical Pharmacist Carl R. Darnall Army Medical Center Fort Hood, TX |
Employment: Department of the Army/Department of Defense; CVS/Pharmacy; PRN staff pharmacist |
Amy C. Lovell Student Pharmacist University of Kentucky College of Pharmacy Lexington, KY |
No Relevant Financial Relationships to Disclose |
Jodie V. Malhotra, PharmD Clinical Pharmacy Specialist, Behavioral Health Denver Health Medical Center Denver, CO |
No Relevant Financial Relationships to Disclose |
Jehan Marino, PharmD, BCPP Assistant Professor of Pharmacy Practice Nova Southeastern University Fort Lauderdale, FL |
Employment: Nova Southeastern University, Assistant Professor of Pharmacy Practice |
Cindy A. Mascarenas, PharmD, MS, BCPP Clinical Pharmacy Specialist, Psychiatry South Texas VHS San Antonio, TX |
No Relevant Financial Relationships to Disclose |
Gerald P. Overman, PharmD, BCPP Program Committee Board Liaison Clinical Pharmacy Specialist National Institutes of Health Washington, DC |
No Relevant Financial Relationships to Disclose |
Jill Reynoldson, PharmD, BCPP Pharmacy Manager Genoa Healthcare Lee’s Summit, MO |
No Relevant Financial Relationships to Disclose |
Tawny L. Smith, PharmD, BCPP Program Committee Chair Clinical Pharmacy Specialist, Psychiatry Seton Family of Hospitals Austin, TX |
No Relevant Financial Relationships to Disclose |
Jennifer L. Zacher, PharmD, BCPP Clinical Pharmacy Specialist Captain James A. Lovell Federal Health Care Center North Chicago, IL |
No Relevant Financial Relationships to Disclose |
2012 CPNP Recertification Committee
Disclosures of Interest
Name | Disclosures of Interest |
---|---|
Nancy C. Brahm, PharmD, BCPP, CGP Clinical Associate Professor University of Oklahoma Tulsa, OK |
No Relevant Financial Relationships to Disclose |
Marshall E. Cates, PharmD, BCPP, FASHP Professor of Pharmacy Practice Samford University McWhorter School of Pharmacy Birmingham, AL |
No Relevant Financial Relationships to Disclose |
Jill A. Fowler, PharmD, BCPP Clinical Pharmacy Specialist, Psychiatry University of Iowa Hospitals and Clinics Iowa City, IA |
No Relevant Financial Relationships to Disclose |
Beth M. Hall, PharmD, BCPP Director of Pharmacy Fulton State Hospital Fulton, MO |
Employment: Clinical Manager for Pharmacy Systems, Inc. placed at Fulton State Hospital |
Cynthia K. Kirkwood, PharmD, BCPP |
Employment: Virginia Commonwealth University, Professor of Pharmacy |
Mitsi H. Lizer, PharmD, BCPP Associate Professor of Pharmacy Practice Shenandoah University School of Pharmacy Winchester, VA |
Employment: Shenandoah University School of Pharmacy |
Rex S. Lott, PharmD, BCPP Recertification Committee Board Liaison Professor of Pharmacy Practice Idaho State University College of Pharmacy Boise, ID |
External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Eisai Pharmaceuticals: Consultant Dr. Lott did not participate in the planning of any presentations related to products offered through this pharmaceutical company. |
Sarah T. Melton, PharmD, BCACP, BCPP, CGP, FASCP Recertification Committee Chair Clinical Pharmacist C-Health, PC Lebanon, VA |
Employment: C-Health, PC, Clinical Pharmacist |
Sudha Narayanaswamy, PharmD, BCPP |
Employment: GNYHA Services, Inc., Assistant Vice President, Clinical Pharmacy Program External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Pharmacy Consultant for Hemodialysis at a hospital in NJ, General Advisory Board, My Gateway to Overcoming Autism in Life, MyGoal, Inc Dr. Narayanaswamy did not participate in the planning of any presentations related to products related to hemodialysis or Autism. |
Tara Purvis, PharmD, BCPP Clinical Pharmacist VA Sierra Nevada Healthcare System Reno, NV |
No Relevant Financial Relationships to Disclose |
Megan M. Sarashinsky, PharmD, BCPP Clinical Pharmacy Specialist CJW Medical Center Richmond, VA |
No Relevant Financial Relationships to Disclose |
Craig Straley, PharmD, BCPP Professor of Pharmacy Practice Ferris State University Battle Creek, MI |
Financial Interests: Johnson and Johnson stock holdings, Pfizer, Inc. stock Dr. Straley did not participate in the planning of any presentations related to products offered through these pharmaceutical companies. |
Rebecca J. Waite, PharmD, BCPP Assistant Professor D’Youville College Buffalo, NY |
No Relevant Financial Relationships to Disclose |
Off-Label Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA (see faculty information and disclosures). The opinions expressed in the educational activity do not necessarily represent the views of CPNP and any educational partners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Presentation-Specific Disclosure: Stoner: My presentation will include discussion of off-label, experimental, and /or investigational use of drugs or devices. I may discuss treatment for EPS, dystonia, and tardive dyskinesia which may include off-label uses of medications. This may include the following: clozapine, quetiapine, lurasidone, asenapine, risperidone, olanzapine, ziprasidone, iloperidone, vitamin E, atropine, ipratropium bromide, benztropine, diphenhydramine, and trihexyphenidyl.